Brickell Biotech Correlations
| BBIDelisted Stock | USD 1.79 0.34 23.45% |
The current 90-days correlation between Brickell Biotech and Valhi Inc is 0.18 (i.e., Average diversification). The correlation of Brickell Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Brickell Biotech Correlation With Market
Good diversification
The correlation between Brickell Biotech and DJI is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Brickell Biotech and DJI in the same portfolio, assuming nothing else is changed.
Brickell |
Moving against Brickell Stock
| 0.7 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
| 0.67 | BAC | Bank of America Sell-off Trend | PairCorr |
| 0.64 | IBM | International Business Sell-off Trend | PairCorr |
| 0.62 | T | ATT Inc Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.52 | WMT | Walmart Sell-off Trend | PairCorr |
| 0.51 | VZ | Verizon Communications Fiscal Year End 28th of January 2025 | PairCorr |
| 0.49 | MSFT | Microsoft | PairCorr |
| 0.46 | KO | Coca Cola Aggressive Push | PairCorr |
| 0.39 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.38 | HPQ | HP Inc Fiscal Year End 19th of November 2024 | PairCorr |
| 0.34 | MMM | 3M Company Trending | PairCorr |
| 0.31 | DD | Dupont De Nemours Financial Report 7th of August 2024 | PairCorr |
Related Correlations Analysis
| 0.42 | 0.52 | 0.46 | 0.0 | 0.27 | 0.44 | VHI | ||
| 0.42 | -0.08 | 0.76 | -0.2 | 0.35 | 0.82 | HWKN | ||
| 0.52 | -0.08 | 0.27 | 0.42 | 0.1 | -0.12 | VSCO | ||
| 0.46 | 0.76 | 0.27 | -0.1 | 0.49 | 0.6 | SXT | ||
| 0.0 | -0.2 | 0.42 | -0.1 | -0.26 | -0.51 | MOS | ||
| 0.27 | 0.35 | 0.1 | 0.49 | -0.26 | 0.38 | HIBB | ||
| 0.44 | 0.82 | -0.12 | 0.6 | -0.51 | 0.38 | BURL | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Brickell Stock performing well and Brickell Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Brickell Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| VHI | 2.75 | 0.39 | 0.13 | 0.39 | 2.74 | 6.51 | 16.61 | |||
| HWKN | 1.69 | 0.50 | 0.27 | 0.94 | 1.42 | 4.42 | 12.90 | |||
| VSCO | 2.73 | 0.10 | 0.03 | 0.16 | 3.59 | 6.14 | 19.75 | |||
| SXT | 0.89 | 0.21 | 0.21 | 0.42 | 0.56 | 2.18 | 5.00 | |||
| MOS | 1.57 | (0.10) | 0.00 | (0.06) | 0.00 | 2.92 | 7.96 | |||
| HIBB | 0.65 | 0.33 | 0.92 | (3.46) | 0.00 | 0.56 | 19.75 | |||
| BURL | 1.70 | 0.45 | 0.30 | 0.47 | 1.26 | 3.92 | 20.59 |
Brickell Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Brickell Biotech stock to make a market-neutral strategy. Peer analysis of Brickell Biotech could also be used in its relative valuation, which is a method of valuing Brickell Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Brickell Biotech Corporate Management
| Albert II | CFO Officer | Profile | |
| Andrew Sklawer | President, CoFounder | Profile | |
| Nancy Seretta | VP Operations | Profile | |
| PM MBA | VP Operations | Profile | |
| Gary Walker | Chief Officer | Profile | |
| David JD | G Officer | Profile | |
| Attorney Brown | CEO Director | Profile |
Still Interested in Brickell Biotech?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.